MedPath

Analgesic efficacy a nerve blockade in the mid thigh for outpatient knee anterior cruciate ligament surgery

Conditions
Mid thigh saphenous nerve block with levobupivacain, as compared to femoral nerve block, in patients undergoing anterior cruciate ligament surgery
Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Registration Number
EUCTR2013-003684-54-NL
Lead Sponsor
Academic Medical Center Amsterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Informed consent, age 18-65 years, ASA status I - III, rupture of the anterior cruciate ligament.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 50
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range 0

Exclusion Criteria

Inability to perform written informed consent, contraindication for regional anesthesia, contraindication for general anesthesia, allergy against local anesthetics, BMI > 35, pre-existing diagnosed neuropathy of the operated leg, ingestion of strong opioids, pregnancy or breastfeeding status. History of significant cardiovascular disease (MI, CVA, peripheral vascular disease)

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Readiness to discharge in hours and according to Post-Anesthetic Discharge Scoring System (PADSS);Secondary Objective: - VAS score <br>- Overall Benefit of Analgesia Score (OBAS)<br>- Lysholm score<br>- SF-12<br>- Sensory blockade extent <br>- Time to rescue analgesic (morphine postoperatively)<br>- Total analgesic consumption (telephone interview)<br>- Time to mobilization (telephone interview)<br>- Knee function will be done by the Knee Society 6 weeks after surgery<br>- Incidence of falls or near falls;Primary end point(s): Shortening of readiness to discharge in hours (20%) ;Timepoint(s) of evaluation of this end point: Post-operatively on day of surgery
Secondary Outcome Measures
NameTimeMethod
Timepoint(s) of evaluation of this end point: - VAS score hourly until discharge, and on the morning and evening of the first postoperative day (telephone interview) together with OBAS on first postoperative day). <br>-Overall Benefit of Analgesia Score (OBAS), determined on the day of surgery, and the first postoperative day.[23]<br>D 0:<br>- KOOS-, IKDC questionnaire, SF12- Sensory blockade extent one hour postoperatively (focusing on concomitant blockade of the saphenous or femoral nerve). <br>- Time to rescue analgesic (morphine postoperatively)<br>- Total analgesic consumption (telephone interview)<br>- Time to mobilization (telephone interview)<br>D1- OBAS (telephone interview)<br>- Knee function will be done by the Knee Society 6 weeks after surgery<br>- Incidence of falls or near falls 6 weeks<br>- WOMAC, SF-12;Secondary end point(s): The secundary endpoints are expected to be at least as effective compared to the control group
© Copyright 2025. All Rights Reserved by MedPath